Hybridoma technology Flashcards

1
Q

who founded hybridoma technology

A

George Kohler and Cesar Milstein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

George Kohler and Cesar Milstein won the

A

nobel prize in physiology of medicine in 1984

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

aim of hybridoma technology

A

to produce monoclonal antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

hybridoma technology allows

A

the identification and culture of cells secretion identical antibodies with pre-defined specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

basic mechanism of hybridoma technology

A

A single clone of cells secreting a single
antibody is made by fusing a B cell (Ig+ splenocyte
with finite lifespan) with a myeloma cell (cancerous
Ig- B cell with infinite lifespan)

The resulting hydrid cells (HYBRIDOMAS) each
make a specific monoclonal antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

B cells

A

Ig+ splenocyte with finite lifespan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

myeloma cell

A

cancerous, Ig- B cell with infinite lifespan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

hybridisation process takes how many injection of specific antigen?

A

4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

the 4 injections cause

A

antibody switching, meaning antibodies become more and more specific to the antigen
- affinity increasing as immunisation continues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hybridisation process

A

1) inject mice with antigen of interest (directly into spleen)
2) antigen goes into blood stream and activates B cells
3) within first few days activation of multivalent IgMs
4) as immunising continues (every 2 week) the immune response builds up: IgM- IgG
5) then blood serum retrieved from mouse by cutting tail
6) serum tested for response to target antigen
7) if response large enough, the mouse it euthanised and spleens removed
8) B cells isolated for hybridisation
9) spleen B cell (splenocyte) fused with myeloma cells in vitro
10) left with a mixture of useful hybrid cells and un-useful unfused myeloma and splenocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

within the first few days

A

activation of multivalent IgMs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how long between each injection

A

2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

IgG

A

best form of antibody for therapy and diagnostics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

splenocyte

A

spleen B cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

myeloma

A

cancer cells which are immortalised and Ig-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is used to isolate hybrid cells

A

HAT medium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

HAT medium used to

A

isolate hybrid cells by knocking out splenocytes and B cells which haven’t fused

18
Q

hybrids produced through this process

A

will produce different antibodies (polyclonal response)

19
Q

single cel hybrids put into a

A

96 well culture plate

20
Q

what is used on the 96 well culture plate

A

ELISA to identify wells of interest

21
Q

myeloma cells are

A

immortalised and unable to produce antibodies

22
Q

what do myeloma cells not have

23
Q

without HGPRT myeloma cells are not able to

A

survive in the HAT medium

24
Q

HAT medium is used to

A

kill all unfused cells

25
why does the HAT medium kill myeloma cells
within the HAT medium is Aminopterin which blocks the main biosynthetic pathways for nucleic acid - stops cells from producing RNA and DNA. Two salvage pathways exist, which rely on two enzymes (hypoxanthine and thymidine kinase. Both cells types have thymidine kinase, so both can make DNA. Only cells with with HGPRT can make RNA. Myeloma cells do not have HGPRT
26
what blocks the biosynthetic pathways for nucleic acid
aminopterin
27
which enzymes are needed for salvage nucleic acid biosynthesis
hypoxanthine and thymidine kinase
28
both cells have
thymidine kinase
29
spleen cells are are
HGPRT +
30
myeloma cells are
HGPRT -
31
myeloma has thymidine kinase but not
hypoxanthine - cannot make RNA- dies
32
myeloma cells are HCPT - therefore
not able to use salvage pathway for RNA synthesis- therefore dies
33
why do spleen cells die in HAT culture
not able to grow i long-term culture (not immortal
34
hybridoma cells can grown in HAT medium because
HGPRT from the spleen cell (RNA synthesis) and importability from myeloma cells
35
although hybridoma cells can grow in HAT medium what they do need
an exogenous supply of H and T.
36
single hybrid cells are then out into a
single well
37
hybridoma cells continue diving in vitro due to
immortal nature of myeloma cells- give ability to be able to live outside the body
38
hybridoma cells divide every
12 hours
39
each well will be producing the same
B cell and therefore antibodies
40
how can hybridomas be stored indefinitely
by freezing in liquid nitrogen
41
when you want more antibodies
you allow them to thaw- will start diving again, producing more monoclonal antibodies